Aveanna Healthcare Holdings Inc.
AVAH · NASDAQ
9/27/2025 | 6/28/2025 | 3/29/2025 | 12/28/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.67 | 0.02 | -0.61 | -0.05 |
| FCF Yield | 1.71% | 5.00% | -1.05% | 1.32% |
| EV / EBITDA | 54.38 | 27.54 | 44.37 | 30.47 |
| Quality | ||||
| ROIC | 4.13% | 3.16% | 2.04% | 3.84% |
| Gross Margin | 32.19% | 35.76% | 32.82% | 33.03% |
| Cash Conversion Ratio | 2.36 | 1.91 | -1.66 | 0.46 |
| Growth | ||||
| Revenue 3-Year CAGR | 7.04% | 5.92% | 5.09% | 4.23% |
| Free Cash Flow Growth | -38.18% | 559.38% | -192.45% | -56.30% |
| Safety | ||||
| Net Debt / EBITDA | 21.54 | 15.96 | 24.19 | 17.70 |
| Interest Coverage | 1.60 | 2.22 | 1.43 | 1.20 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 40.16 | 37.88 | 41.84 | 38.65 |